Suppr超能文献

台湾地区乳腺癌预防与生存的中医药研究:一项流行病学研究的叙述性综述。

Traditional Chinese Medicine Herbs for Breast Cancer Prevention and Survival: A Narrative Review of Epidemiological Studies from Taiwan.

机构信息

Integrative Medicine Service, Memorial Sloan Kettering Cancer Center, 321 East 61st Street, 4th Floor, New York, NY, 10065, USA.

Department of Epidemiology and Biostatistics, Memorial Sloan Kettering, Cancer Center, New York, NY, USA.

出版信息

Curr Oncol Rep. 2024 Nov;26(11):1321-1333. doi: 10.1007/s11912-024-01595-6. Epub 2024 Oct 3.

Abstract

PURPOSE OF REVIEW

This review aims to describe the association of integrating traditional Chinese medicine (TCM) herbs into conventional medicine (CM) in preventing breast cancer and improving survival rates among breast cancer patients of Taiwan.

RECENT FINDINGS

Of 7 relevant studies, spanning 2014-2023, 4 investigated breast cancer risk in women with menopausal symptoms and other comorbidities. All 4 reported that TCM herbal use was associated with lower risks of developing breast cancer. Three studies investigated survival in newly-diagnosed breast cancer patients receiving CM. All reported that adjunctive TCM users had lower mortality rates than CM-only patients. However, the heterogeneity of study designs, populations, and interventions may limit the generalizability and robustness of the findings. TCM herbs may promote breast cancer prevention and survival when used alongside CM. More rigorous observational research and clinical trials in specific patient populations are needed to guide clinical decision-making.

摘要

目的综述

本综述旨在描述将中药(TCM)与常规医学(CM)相结合,预防台湾乳腺癌患者的乳腺癌和提高生存率。

最近的发现

在 7 项相关研究中,跨度为 2014-2023 年,有 4 项研究调查了有更年期症状和其他合并症的女性的乳腺癌风险。所有 4 项研究都报告说,使用 TCM 草药与降低患乳腺癌的风险有关。有 3 项研究调查了接受 CM 治疗的新诊断乳腺癌患者的生存情况。所有报告均指出,辅助 TCM 使用者的死亡率低于仅接受 CM 治疗的患者。然而,研究设计、人群和干预措施的异质性可能限制了研究结果的普遍性和稳健性。当与 CM 一起使用时,TCM 草药可能有助于预防乳腺癌和提高生存率。需要在特定患者人群中进行更严格的观察性研究和临床试验,以指导临床决策。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验